The Veesler Lab Profile picture
Dec 14, 2021 8 tweets 9 min read Read on X
Here is our assessment of #SARSCoV2 #Omicron receptor usage and immune evasion in collaboration with the team of @DavideCorti6 @Vir_Biotech

Led by Elisabetta Cameroni, Christian Saliba, @johnbowenbio & Laura E. Rosen

@HHMINEWS @UWBiochemistry

biorxiv.org/content/10.110…

1/8
#SARSCoV2 #Omicron harbors a staggering 37 amino acid mutations in the spike with 15 of them in the receptor-binding domain (RBD), which is the main target of neutralizing antibodies. The number and positions of these mutations is concerning for tropism & immune evasion.

2/8
We found that the #SARSCoV2 #Omicron RBD has ~2.5-fold enhanced ACE2 binding affinity, relative to the Wuhan-Hu-1 RBD, similar to what we previously showed for the Beta variant of concern.

nature.com/articles/s4158…

3/8
We discovered that the #SARSCoV2 #Omicron RBD, but not Alpha or Beta RBDs, bound mouse ACE2, likely due to Q493R which is similar to Q493K isolated upon mouse adaptation by @Baric_Lab

sciencedirect.com/science/articl…

These data *putatively* reflect #Omicron expanded tropism

4/8
#SARSCoV2 #Omicron immune evasion reduces plasma neutralizing activity up to 57x (convalescent) and up to 30-40x for Pfizer, Moderna or Astrazeneca vaccinees.
No neutralizing activity left with J&J (1x), Sputnik and Sinopharm for most subjects analyzed.

5/8
#SARSCoV2 #Omicron mutations knock out 7 out of 8 monoclonal antibodies currently used in the clinic. Only S309, the parent of VIR-7832, retain neutralizing activity, with ~3x reduction relative to Wuhan-Hu-1.

We described S309 early last year.
nature.com/articles/s4158…

6/8
A few other broadly neutralizing sarbecovirus antibodies are inhibiting #SARSCoV2 #Omicron, including S2X259, S2H97 and S2K146. This is good news and shows that targeting conserved sarbecovirus RBD epitopes provides resilience to viral evolution!

7/8
Thank you so much @SamK_Zepeda Kaiti Sprouse @coronalexington and all our wonderful collaborators including @atelentia @LanzavecchiaB @HelenChuMD @LucaPiccoli9 @SkiClimbSciNick @DrLisaPurcell and many others not on twitter!

8/8

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with The Veesler Lab

The Veesler Lab Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @veeslerlab

Mar 14
A few months ago, we asked if imprinting impacts immune responses to the recently updated XBB.1.5 spike (S) #COVID19 booster? The peer-reviewed version of our manuscript is now available
@HHMINEWS @UWBiochemistry

1/11

cell.com/immunity/fullt…
The original thread describing our results is below


2/11
During the review process, we added data showing elicitation of broadly neutralizing polyclonal plasma antibodies (Abs) against a wider ranger of #SARSCoV2 variants (now including HK.3 and JN.1) and at a later time point (~50 days post XBB.1.5 booster vaccination)

3/11 Image
Read 11 tweets
Jan 10
Are you wondering how the human coronavirus HKU1 recognizes the TMPRSS2 host receptor?

Find out in our @biorxivpreprint led by
@Dr_MattMcCallum @YoungjunPark11

@HHMINEWS @UWBiochemistry

1/26
biorxiv.org/content/10.110…
HKU1 was discovered in 2005 from a patient with pneumonia (it was circulating for ≥10 years) and is endemic in humans. HKU1 is an embecovirus, a subgenus for which the entry process into cells is less well understood than for most other betaCoVs such as #SARSCoV2

2/26
Recently, @Virus_Immunity @JBuchrieser @virusfusion007 and colleagues showed that human TMPRSS2 is an entry receptor for HKU1

3/26

nature.com/articles/s4158…
Read 26 tweets
Dec 14, 2023
Can we design #COVID19 vaccines that are largely insensitive to viral evolution? Find out by reading our @biorxivpreprint preprint

Led by @0327jimin

@HHMINEWS @UWBiochemistry

1/22

biorxiv.org/content/10.110…
Coronavirus spike (S) glycoproteins comprise the S1 subunit, which mediates attachment to host receptor(s), and the S2 subunit (fusion machinery) that promotes fusion of the viral and host membranes to initiate infection

2/22 Image
The S2 subunit (fusion machinery) is much more conserved than the S1 subunit (comprising the RBD and NTD), and harbors several antigenic sites targeted by broadly neutralizing and protective monoclonal antibodies (Abs)

3/22
Read 22 tweets
Dec 1, 2023
Is imprinting impacting immune responses to the recently updated XBB.1.5 spike (S) #COVID19 booster? Find out by reading our preprint or this thread!

Led by @aletortorici

@HHMINEWS @UWBiochemistry

1/18

biorxiv.org/content/10.110…
Immune imprinting - AKA original antigenic sin - describes how the first exposure to a virus shapes the immunological outcome of subsequent exposures to antigenically related strains.

2/18
Last year, we showed that Omicron infection of Wuhan-Hu-1 (Wu) mRNA vaccinees recalls cross-reactive memory B cells specific for epitopes shared by multiple #SARSCoV2 variants rather than priming naive B cells binding Omicron RBD-specific epitopes

3/18
science.org/doi/10.1126/sc…
Image
Read 18 tweets
Sep 14, 2023
How do bat-borne sarbecoviruses (i.e. SARS-CoV-1/2-like viruses) interact with host receptors and are we ready for a possible future pandemic?

Find out in this study led by @0327jimin & @Sam_K_Zepeda !

@HHMINEWS @UWBiochemistry

1/23

biorxiv.org/content/10.110…
Spillover of SARS-CoV-1 and #SARSCoV2 from Rinolophus bat origin led to the SARS epidemic and the #COVID19 pandemic. Reports of additional sarbecovirus spillovers & detection in Rhinolophus bats and other animals underscore their recurrent zoonotic threat to public health

2/23
Clade 3 sarbecoviruses have been identified in Rhinolophus bats in Europe and Africa and comprise uncharacterized ACE2-utilizing viruses, broadening the range of sarbecoviruses with spillover potential

3/22
Read 23 tweets
Aug 21, 2023
Have you heard of the recently emerged Langya virus (LayV) which was detected in humans last year? Find out more by reading our @biorxivpreprint led by @pbpwang @Dr_MattMcCallum & Lianying Yan!

1/19

biorxiv.org/content/10.110…
LayV is a recently discovered henipavirus (HNV), isolated from febrile patients in China, harboring a genome distantly related to that of Nipah virus (NiV) and Hendra virus (HeV)



2/19nejm.org/doi/full/10.10…
Although LayV is related to the highly lethal Nipah virus and Hendra virus, it is set apart due to its extraordinary genetic divergence and the fact that it is the first confirmed human-infecting HNV from shrew origin

3/19
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(